Koh, Jaemoon
Kim, Sehui
Kim, Joong-Yub
Yim, Jae-Joon
Kwak, Nakwon
Funding for this research was provided by:
Seoul National University Hospital (0320220070)
Article History
Received: 17 April 2024
Accepted: 7 August 2024
First Online: 13 August 2024
Declarations
:
: The Institutional Review Board of the Seoul National University Hospital approved the study protocol (IRB No. 2009-048-1155).
: Not applicable.
: Dr. JJ Yim has served as the overall or institutional principal investigator for clinical trials related to non-tuberculous mycobacterial pulmonary disease sponsored by LigaChem Biosciences, Insmed and AN2 Therapeutics. Additionally, he has received several drugs free of charge as a principal investigator for previous trials related to tuberculosis from Pfizer, Otsuka, and Yuhan.